METTL3 and breast cancer: Zhou et al. [43] demonstrated that METTL3-mediated m6A modification on long noncoding RNA (lncRNA) KCNQ1OT1 promotes ADR resistance in BC by regulating the miR-103a-3p/multidrug resistance protein 1 (MDR1) axis.